Osaic Holdings’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.99K | Buy |
5,517
+5,017
| +1,003% | +$8.17K | ﹤0.01% | 5834 |
|
2025
Q1 | $595 | Sell |
500
-5,017
| -91% | -$5.97K | ﹤0.01% | 6795 |
|
2024
Q4 | $8.99K | Buy |
5,517
+250
| +5% | +$408 | ﹤0.01% | 5792 |
|
2024
Q3 | $20.1K | Hold |
5,267
| – | – | ﹤0.01% | 5334 |
|
2024
Q2 | $15.4K | Buy |
5,267
+17
| +0.3% | +$50 | ﹤0.01% | 5466 |
|
2024
Q1 | $20.8K | Buy |
5,250
+5,000
| +2,000% | +$19.8K | ﹤0.01% | 5309 |
|
2023
Q4 | $1.24K | Sell |
250
-6,000
| -96% | -$29.8K | ﹤0.01% | 6535 |
|
2023
Q3 | $31.6K | Buy |
6,250
+4,250
| +213% | +$21.5K | ﹤0.01% | 5280 |
|
2023
Q2 | $10.1K | Sell |
2,000
-500
| -20% | -$2.52K | ﹤0.01% | 5922 |
|
2023
Q1 | $15.4K | Buy |
2,500
+1,498
| +150% | +$9.21K | ﹤0.01% | 5701 |
|
2022
Q4 | $13K | Buy |
1,002
+2
| +0.2% | +$26 | ﹤0.01% | 5797 |
|
2022
Q3 | $3K | Sell |
1,000
-11
| -1% | -$33 | ﹤0.01% | 6584 |
|
2022
Q2 | $4K | Sell |
1,011
-120
| -11% | -$475 | ﹤0.01% | 6569 |
|
2022
Q1 | $7K | Sell |
1,131
-250
| -18% | -$1.55K | ﹤0.01% | 6288 |
|
2021
Q4 | $11K | Sell |
1,381
-250
| -15% | -$1.99K | ﹤0.01% | 6138 |
|
2021
Q3 | $25K | Sell |
1,631
-880
| -35% | -$13.5K | ﹤0.01% | 5607 |
|
2021
Q2 | $32K | Buy |
2,511
+1,000
| +66% | +$12.7K | ﹤0.01% | 5359 |
|
2021
Q1 | $7K | Buy |
1,511
+700
| +86% | +$3.24K | ﹤0.01% | 5993 |
|
2020
Q4 | $2K | Hold |
811
| – | – | ﹤0.01% | 5999 |
|
2020
Q3 | $2K | Buy |
811
+800
| +7,273% | +$1.97K | ﹤0.01% | 5812 |
|
2020
Q2 | $0 | Hold |
11
| – | – | ﹤0.01% | 6147 |
|
2020
Q1 | $0 | Buy |
+11
| New | – | ﹤0.01% | 6039 |
|